Health Care & Life Sciences » Pharmaceuticals | Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.28
Market Cap
$403.19 M
Shares Outstanding
102.85 M
Public Float
95.51 M

Profile

Address
355 Alhambra Circle
Coral Gables Florida 33134
United States
Employees -
Website http://www.catalystpharma.com
Updated 07/08/2019
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette's disorder. The company was founded by McEnany J.

Financials

View All

Patrick J. McEnany
Chairman, President & Chief Executive Officer
David S. Tierney
Independent Director